Toya Nath Baral

Camelid immunoglobulins and nanobody technology

Serge Muyldermans, Toya Nath Baral, V. Cortez Retamozzo et al. · Veterinary Immunology and Immunopathology · 2008 · 522 citations · Full text

Vaccination, Veterinary Vaccine, Immunoengineering +5

Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor

Toya Nath Baral, Stefan Magez, Benoı̂t Stijlemans et al. · Nature Medicine · 2006 · 163 citations

Nanomedicine, Translational Medicine, Experimental Therapy +5

Differential tumor-targeting abilities of three single-domain antibody formats

Andrea M. Bell, Zheng J. Wang, Mehdi Arbabi‐Ghahroudi et al. · Cancer Letters · 2009 · 115 citations · Full text

Differential Tumor-targeting Abilities, Tumor Immunology, Immunology +5

Interferon‐γ and Nitric Oxide in Combination with Antibodies Are Key Protective Host Immune Factors during<i>Trypanosoma congolense</i>Tc13 Infections

Stefan Magez, Magdalena Radwanska, Michael Drennan et al. · The Journal of Infectious Diseases · 2006 · 110 citations · Full text

Ifn- Gamma, Immune Activation, Nitric Oxide +19

Transient expression and purification of chimeric heavy chain antibodies

Jianbing Zhang, Xin Liu, Andrea M. Bell et al. · Protein Expression and Purification · 2008 · 104 citations

Transient Expression, Autoimmune Disease, Immunology +7